剖宫产术中行子宫肌瘤剔除术的临床应用

目的探讨临床剖宫产术中同时行子宫肌瘤剔除术的临床疗效和安全性。方法选取2011年月至2011年12月期间收治的剖宫产术中同时行子宫肌瘤剔除术的80例妊娠合并子宫肌瘤患者为研究组,并选取同期仅进行剖宫产术的80例妊娠合并子宫肌瘤患者为对照组,观察两组的应用效果。结果研究组手术时间明显高于对照组,差异有统计学意义(P<0.05)。研究组和对照组的术中出血量、产后出血量、缩宫素用量比较,差异无统计学意义(P>0.05)。研究组和对照组术后血红蛋白、住院时间、肛门排气时间比较,差异无统计学意义(P>0.05)。研究组的并发症发生率为2.5%,对照组的并发症发生率为3.8%,差异无统计学意义(P>0.05)。结论临床中妊娠合并有子宫肌瘤的患者在实施剖宫产术中同时行子宫肌瘤剔除术是可行的,值得临床应用与推广。

Clinical analysis of cesarean simultaneously myomectomy

Objective To investigate the clinical efficiency and safety of conducting myomectomy during clinical cesarean section. Methods Select 80 cases of pregnant women who were received myomec- tomy during cesarean section from January 2011 to December 2011 as study group and 80 cases of pregnant women who were only received cesarean section as control group. Results The operation time of study group was longer than control group, and the difference was statistically significant （ P 〈 0. 05 ） ; the blood losses during operation and after delivery and oxytocin dosage of the two groups showed no statistically signif- icant difference （P 〉 0. 05 ）. As for hemoglobin, hospitalization time and anal exhaust time, the two groups showed no statistically significant difference （ P 〉 0.05 ）. The complication occurrence rate of study group was 2. 5% ,while the control group 3.8% and there is no statistically significant difference between the two groups （P 〉 0. 05）. Conclusion For pregnancy women with uterine fibroid in clinical, conducting myo- mectomy during cesarean section is feasible and worthy of clinical application and promotion.